GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Kimia Farma Tbk (ISX:KAEF) » Definitions » Debt-to-Revenue

PT Kimia Farma Tbk (ISX:KAEF) Debt-to-Revenue : 0.71 (As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is PT Kimia Farma Tbk Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

PT Kimia Farma Tbk's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was Rp5,187,911 Mil. PT Kimia Farma Tbk's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was Rp2,385,694 Mil. PT Kimia Farma Tbk's annualized Revenue for the quarter that ended in Sep. 2024 was Rp10,602,274 Mil. PT Kimia Farma Tbk's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 was 0.71.


PT Kimia Farma Tbk Debt-to-Revenue Historical Data

The historical data trend for PT Kimia Farma Tbk's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kimia Farma Tbk Debt-to-Revenue Chart

PT Kimia Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.88 0.78 0.62 0.88 0.77

PT Kimia Farma Tbk Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 0.86 0.74 0.71 0.71

Competitive Comparison of PT Kimia Farma Tbk's Debt-to-Revenue

For the Medical Distribution subindustry, PT Kimia Farma Tbk's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kimia Farma Tbk's Debt-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Tbk's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where PT Kimia Farma Tbk's Debt-to-Revenue falls into.



PT Kimia Farma Tbk Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

PT Kimia Farma Tbk's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(6938080.437 + 762934.697) / 9965033.049
=0.77

PT Kimia Farma Tbk's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(5187911.351 + 2385694.01) / 10602274.052
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.


PT Kimia Farma Tbk Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of PT Kimia Farma Tbk's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Kimia Farma Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.

PT Kimia Farma Tbk Headlines

No Headlines